Style | Citing Format |
---|---|
MLA | Gheini A, Pourya A, Pooria A. "Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes." Cardiovascular and Hematological Disorders - Drug Targets, vol. 20, no. 4, 2020, pp. 249-259. |
APA | Gheini A, Pourya A, Pooria A (2020). Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes. Cardiovascular and Hematological Disorders - Drug Targets, 20(4), 249-259. |
Chicago | Gheini A, Pourya A, Pooria A. "Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes." Cardiovascular and Hematological Disorders - Drug Targets 20, no. 4 (2020): 249-259. |
Harvard | Gheini A, Pourya A, Pooria A (2020) 'Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes', Cardiovascular and Hematological Disorders - Drug Targets, 20(4), pp. 249-259. |
Vancouver | Gheini A, Pourya A, Pooria A. Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes. Cardiovascular and Hematological Disorders - Drug Targets. 2020;20(4):249-259. |
BibTex | @article{ author = {Gheini A and Pourya A and Pooria A}, title = {Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes}, journal = {Cardiovascular and Hematological Disorders - Drug Targets}, volume = {20}, number = {4}, pages = {249-259}, year = {2020} } |
RIS | TY - JOUR AU - Gheini A AU - Pourya A AU - Pooria A TI - Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes JO - Cardiovascular and Hematological Disorders - Drug Targets VL - 20 IS - 4 SP - 249 EP - 259 PY - 2020 ER - |